615731650	615731650	CD	B-NP	O
|	|	NN	I-NP	O
NCMC	NCMC	NN	I-NP	O
|	|	NN	I-NP	O
09399642	09399642	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
668470	668470	CD	B-NP	O
|	|	CC	I-NP	O
11/12/2002	11/12/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/1/2002	6/1/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/30/2002	4/30/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WOOWARD	WOOWARD	NNP	B-NP	O
,	,	,	O	O
DANIAL	DANIAL	NNP	B-NP	O
486-15-91-4	486-15-91-4	CD	I-NP	O
S	S	NNP	I-NP	O
Mon	Mon	NNP	I-NP	O
Tala	Tala	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
HEM	HEM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/12/02	6/12/02	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ZAMBORANO	ZAMBORANO	NN	B-NP	B-protein
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
JONAH	JONAH	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q4H	Q4H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
headache	headache	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
HUMULIN	HUMULIN	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
qam	qam	NN	I-NP	O
;	;	:	O	O
15	15	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qpm	qpm	NN	I-NP	B-protein
SC	SC	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
UNITS	UNITS	NNS	I-NP	I-protein
qam	qam	NN	B-NP	I-protein
15	15	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
qpm	qpm	NN	I-NP	I-protein
REG	REG	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
QAC	QAC	NNP	I-NP	O
&	&	CC	I-NP	O
HS	HS	NNP	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
ZESTRIL	ZESTRIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/15/02	1/15/02	CD	B-NP	O
by	by	IN	B-PP	O
GOHRING	GOHRING	NNP	B-NP	O
,	,	,	O	O
AMADO	AMADO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
58257913	58257913	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/15/02	1/15/02	CD	B-NP	O
by	by	IN	B-PP	O
BLOODSWORTH	BLOODSWORTH	NNP	B-NP	O
,	,	,	O	O
RODRIGO	RODRIGO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
38839777	38839777	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-protein
METHADONE	METHADONE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q3H	Q3H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
SENNA	SENNA	NN	I-NP	I-protein
TABLETS	TABLETS	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ZOLOFT	ZOLOFT	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SERTRALINE	SERTRALINE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
VISCOUS	VISCOUS	NNP	I-NP	O
LIDOCAINE	LIDOCAINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LIDOCAINE	LIDOCAINE	NNP	I-NP	O
VISCOUS	VISCOUS	VBZ	B-VP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
15	15	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q3H	Q3H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
mouth	mouth	NN	I-NP	O
pain	pain	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lynwood	Lynwood	NNP	I-NP	O
Guley	Guley	NNP	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
10/24/02	10/24/02	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Alvin	Alvin	NNP	B-NP	O
Crook	Crook	NNP	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
9/21/02	9/21/02	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
aplastic	aplastic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hemochromatosis	hemochromatosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hemochromatosis	hemochromatosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hcv	hcv	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
hep	hep	NN	I-NP	O
B	B	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
-RRB-	-RRB-	SYM	O	O
AVN	AVN	NN	B-NP	O
=	=	SYM	B-VP	O
>	>	SYM	B-NP	O
bilateral	bilateral	JJ	I-NP	O
THR	THR	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
avascular	avascular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
head	head	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
multiple	multiple	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
line	line	NN	B-NP	O
sepsis	sepsis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sepsis	sepsis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pt	Pt	NNP	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
services	service	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

PICC	PICC	NN	B-NP	B-protein
care	care	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Safety	Safety	NN	B-NP	B-protein
Evaluation	Evaluation	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Medication	Medication	NNP	B-NP	O
Compliance	Compliance	NNP	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
diet	diet	NN	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
hydration	hydration	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
38	38	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
fall	fall	NN	I-NP	O
with	with	IN	B-PP	O
hypersomnoloence	hypersomnoloence	NN	B-NP	O
and	and	CC	O	O
facial	facial	JJ	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
dx	dx	NN	I-NP	O
with	with	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
12	12	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chronically	chronically	RB	B-ADJP	O
transfusion	transfusion	NN	I-ADJP	O
dependent	dependent	JJ	I-ADJP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
hct	hct	VBP	B-VP	O
23-25	23-25	CD	B-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	O
9-teens	9-teen	NNS	I-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
developed	develop	VBD	B-VP	O
hemochromatosis	hemochromatosis	NN	B-NP	O
2/2	2/2	CD	B-NP	O
transfusions	transfusion	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
apparently	apparently	RB	B-ADVP	O
fell	fall	VBD	B-VP	O
asleep	asleep	RB	B-ADVP	O
while	while	IN	B-SBAR	O
standing	stand	VBG	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
landed	land	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
face	face	NN	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
mandibular	mandibular	JJ	B-NP	O
X-rays	X-ray	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
med	me	VBD	B-VP	O
managment	managment	NN	B-NP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
issue	issue	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
methadone	methadone	NN	B-NP	O
90	90	CD	I-NP	O
tid	tid	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
taking	take	VBG	B-VP	O
numerous	numerous	JJ	B-NP	O
others	other	NNS	I-NP	O
prn	prn	VBP	B-VP	O
.	.	.	O	O

Course	Course	NN	B-NP	O
by	by	IN	B-PP	O
problem	problem	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aplastic	Aplastic	NNP	B-NP	O
Anemia	Anemia	NNP	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	B-cell_type
initial	initial	JJ	I-NP	I-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hct	hct	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
and	and	CC	O	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
PRBCs	PRBC	NNS	I-NP	B-cell_type
.	.	.	O	O

Platelets	Platelet	NNS	B-NP	B-cell_type
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
bump	bump	VB	I-VP	O
much	much	RB	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
2	2	CD	I-NP	O
units	unit	NNS	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
.	.	.	O	O

PLatlets	PLatlet	NNS	B-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
35	35	CD	B-NP	O
.	.	.	O	O

Hemostasis	Hemostasis	NN	B-NP	O
achieved	achieve	VBN	B-VP	O
of	of	IN	B-PP	O
wounds	wound	NNS	B-NP	O
and	and	CC	O	O
hct	hct	NN	B-NP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
23	23	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Fall	Fall	NNP	B-NP	O
:	:	:	O	O
Fall	Fall	NNP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
hypersomnolence	hypersomnolence	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
over	over	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
and	and	CC	O	O
possible	possible	VB	B-VP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
did	do	VBD	B-VP	O
become	become	VB	I-VP	O
more	more	RBR	B-ADJP	O
alert	alert	JJ	I-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
once	once	RB	I-NP	O
pain	pain	NN	B-NP	O
meds	med	NNS	I-NP	O
changed	change	VBD	B-VP	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
got	get	VBD	B-VP	O
some	some	DT	B-NP	O
sleep	sleep	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
:	:	:	O	O
Pain	Pain	NN	B-NP	O
consultant	consultant	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
changing	change	VBG	I-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
methadone	methadone	NN	B-NP	O
30	30	CD	I-NP	O
tid	tid	NN	I-NP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
q3hr	q3hr	NN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	B-protein
breakthrough	breakthrough	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DMII	DMII	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
50-330	50-330	CD	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admit	admit	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
nph	nph	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Noted	Note	VBN	B-NP	O
significant	significant	JJ	I-NP	O
dietary	dietary	JJ	I-NP	O
indiscretion	indiscretion	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Follow-Up	Follow-Up	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
supply	supply	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
meds	med	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Meharry	Meharry	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Laferriere	Laferriere	NNP	I-NP	O
10/11	10/11	CD	I-NP	O
and	and	CC	O	O
Emilio	Emilio	NNP	B-NP	O
Leiferman	Leiferman	NNP	I-NP	O
7/27	7/27	CD	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
pain	pain	NN	B-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
for	for	IN	B-PP	O
:	:	:	O	O
PICC	PICC	NN	B-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
safety	safety	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
,	,	,	O	O
check	check	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hydration	hydration	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MORICLE	MORICLE	NNP	B-NP	O
,	,	,	O	O
JUAN	JUAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MF61	MF61	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/12/02	6/12/02	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

